Skip to main content

Want a detailed portfolio tracker?

Vericel (VCEL) P/E (2010 - 2026)

Vericel (VCEL) P/E from Jun 30, 2010 to Jun 3, 2026. The TTM Vericel (VCEL) P/E is 81.74. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vericel (VCEL)

YearP/EChange
202681.74-26.31%
2025110.93-58.48%
2024267.18-260.98%
2023-165.97+141.47%
2022-68.73-71.82%
2021-243.93-146.73%
2020522.02-772.65%
2019-77.61-0.39%
2018-77.91+933.94%
2017-7.54+92.93%
2016-3.91+4.00%
2015-3.76+148.42%
2014-1.51+167.34%
2013-0.57-97.80%
2012-25.70-30.77%
2011-37.12-28.91%
2010-52.21N/A

Comparison Vericel (VCEL) P/E with competitors

Vericel (VCEL) P/E is 81.74.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.10-99.87%
ENLVEnlivex Therapeutics Ltd0.15-99.82%
FGENFibroGen Inc0.24-99.71%
TRAWTraws Pharma Inc0.47-99.42%
FBIOFortress Biotech Inc0.71-99.14%
CHRSCoherus Biosciences Inc0.98-98.80%
ORMPOramed Pharmaceuticals Inc1.47-98.20%
AGENAgenus Inc2.05-97.49%
VIVSVivoSim Labs Inc2.54-96.90%
INVAInnoviva Inc3.19-96.10%
CRMDCorMedix Inc3.65-95.54%
ABEOAbeona Therapeutics Inc4.20-94.86%
VXRTVaxart Inc4.26-94.79%
CVACCureVac N.V.4.45-94.56%
SRPTSarepta Therapeutics Inc4.62-94.34%
GLPGGalapagos NV4.86-94.06%
RIGLRigel Pharmaceuticals4.92-93.98%
ZVRAZevra Therapeutics Inc4.97-93.92%
ABUSArbutus Biopharma Corp5.69-93.03%
CGENCompugen Ltd7.38-90.97%
AUPHAurinia Pharmaceuticals Inc9.25-88.68%
ACADAcadia Pharmaceuticals Inc9.59-88.27%
OMEROmeros Corporation9.88-87.91%
PLXProtalix BioTherapeutics Inc9.91-87.88%
SPROSpero Therapeutics Inc10.73-86.87%
ADMAAdma Biologics Inc11.33-86.14%
SVASinovac Biotech Ltd11.44-86.01%
TBPHTheravance Biopharma Inc11.78-85.59%
HRMYHarmony Biosciences Holdings Inc12.18-85.10%
TGTXTG Therapeutics Inc13.18-83.88%
INCYIncyte Corp13.38-83.63%
SABSSAB Biotherapeutics Inc14.06-82.80%
XOMAXOMA Corp14.95-81.72%
REGNRegeneron Pharmaceuticals Inc14.98-81.67%
PBYIPuma Biotechnology Inc15.05-81.59%
EXELExelixis Inc15.79-80.68%
NAGENiagen Bioscience Inc16.35-79.99%
CPRXCatalyst Pharmaceuticals Inc17.34-78.78%
MDXGMimedx Group Inc17.38-78.74%
ARGXArgen X SE23.07-71.78%
HALOHalozyme Therapeutics Inc23.20-71.62%
XOMAOXOMA Corp25.34-68.99%
VRTXVertex Pharmaceuticals Inc25.66-68.61%
XOMAPXOMA Corp25.67-68.60%
CTMXCytomX Therapeutics Inc25.70-68.56%
ASNDAscendis Pharma A/S26.35-67.76%
RPRXRoyalty Pharma plc - Class A27.50-66.36%
SLNOSoleno Therapeutics Inc29.02-64.50%
LGNDLigand Pharmaceuticals Inc - Class B30.19-63.07%
BMRNBiomarin Pharmaceutical Inc37.51-54.12%
APLSApellis Pharmaceuticals Inc39.02-52.26%
KRYSKrystal Biotech Inc39.70-51.44%
GMABGenmab40.20-50.82%
ONCBeiGene Ltd67.03-18.00%
TECHBio-Techne Corp68.59-16.08%
PHARPharming Group N.V.87.74+7.34%
ALNYAlnylam Pharmaceuticals Inc124.93+52.84%
TLXTelix Pharmaceuticals Ltd139.89+71.14%
CORTCorcept Therapeutics Inc158.39+93.77%